A novel drug to prevent ptsd or to reduce the symptoms in individuals already diagnosed with ptsd

Active Project Grant Awarded Last action

Award ID
HT94252410638
Recipient
Awarding agency
Obligated
$633,310

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date 78% complete
Place of performance
Israel

Award details come from USAspending.gov.

About this award

Written by GovTribe AI ·

This federal Project Grant award in the amount of $633,310.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award, with a performance period from July 1, 2024 to June 30, 2027, will fund the University of Haifa in Israel to develop a novel drug to prevent PTSD or reduce symptoms in individuals already diagnosed with PTSD. The University of Haifa has a track record of conducting academic research projects across various medical and scientific domains, including previous federal grant awards from agencies such as the Department of State, Department of the Interior, and Department of the Army. This award represents an opportunity for the University of Haifa to leverage its research expertise to advance innovative solutions addressing critical health challenges facing military personnel.

Quick answers

Who received award HT94252410638?

HT94252410638 was awarded to University Of Haifa by Defense Health Agency (Department of Defense) on July 1, 2024.

How much is award HT94252410638 worth?

$633,310 has been obligated on HT94252410638.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login